Imedlabsp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-03-02
Share capital
50,000.00 PLN
Activity description

Imedlab is a pathology laboratory established in 2023, performing histopathological, histochemical, immunohistochemical and cytological examinations. The laboratory analyzes materials obtained from gastroscopy, bronchoscopy, endoscopy, and core- and fine-needle biopsies, among other procedures.

Registered address
ul. Marszałka Józefa Piłsudskiego 84, 41-902 Bytom, Poland
Website
imedlab.pl
Email
Phone
Social media
Electronic delivery address
AE:PL-64836-94180-EVTTD-27

Financials

Revenue history (in k)

Filing timeliness

1 of 4 financial statements was filed late (for 2022, 2 days late).

  • 202509/06/2026
  • 202404/06/2025
  • 202322/04/2024
  • 202217/07/2023
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 2.06mMedianUSD 91.87kAverageUSD 1.38m
Net profit
This companyUSD 54.74kMedianUSD 2.66kAverageUSD 145.77k
Operating costs
This companyUSD 1.93mMedianUSD 82.72kAverageUSD 1.18m
Assets
This companyUSD 738.54kMedianUSD 39.38kAverageUSD 949.95k

Industry

Offer

  • Histopathological tests
  • Immunohistochemical tests
  • Cytological tests
  • Histochemical tests

Website technology

Website
  • WordPress
  • Elementor

Public procurement

3 tenders recorded as contractor, with a total value of $235,733.

SubjectAmount
Histopathological examinations
–
Neuropathological examinations
–
Call for proposals No. 52/KŚZ/25 for healthcare services consisting of performing histopathological examinations for patients of Szpital Miejski w Rudzie Śląskiej Sp. z o.o.
$235.7K

Authorized Representatives

Bohdan Kozak – Attorney-in-fact (sole)
Mateusz Bohdan Kozak – President

Manner of representation

In the case of a multi-member management board, the President of the Management Board is authorized to make declarations on behalf of the company independently, and the other members of the management board jointly with another member of the management board.

Ownership

OwnerSharesShare valueStake
Michał Zbigniew Cichage 44
197$2,660.7219.7%
Marcin Jakub Dejasage 51
287$3,876.2828.7%
Mateusz Bohdan Kozakage 35
238$3,214.4823.8%
Joanna Lepiarczykage 43
90$1,215.569%
Katarzyna Maria Martela Tomaszekage 39
188$2,539.1718.8%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2022-05-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $1,694,074.

PurposeGross amount
Aid for research and development projects: industrial research
$1.4M
Aid for research and development projects: experimental development
$124.1K
De minimis aid (in accordance with Commission Regulation 2023/2831)
$122.1K

European Funds

ProjectEU co-financing
Development of a prototype of a new-quality system for digital pathology using artificial intelligence
$1.7M

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Unimedsp. z o.o.
Warsaw GenomicsS.A.
Info-Pat sp. z o.o.sp. k.
Masdiagsp. z o.o.
Vitaimmun Drobczyńska, Szachtasp. k.
CytopathS.A.
Gastromedicasp. z o.o.
Zdrowiesp. z o.o.
Allergo-Medsp. z o.o.
Laboratorium Analiz Lekarskich Laborsp. z o.o.

FAQ

Last updated: 2026-10-07